Curcumin supplementation in the treatment of patients with cancer: a systematic review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/200985 |
Resumo: | Feeding with high levels of phytochemicals, including curcumin, may be a therapeutic option for diseases such as cancer which is a public health problem. The aim of this study was to systematically review the results of clinical trials investigating the effect of oral curcumin supplementation on anti-inflammatory and antioxidant profiles, reduction of PSA levels and degree of dermatitis in radiotherapy treatment in cancer patients. The review was carried out based on the items of the PRISMA Statement. A bias risk assessment was performed according to Cochrane Collaboration criteria. Six studies met the eligibility criteria and were included in the systematic review. The results of this study are based on those obtained in the literature on the effect of curcumin on the anti-inflammatory profile, on reducing dermatitis, on PSA alteration and on anti-oxidant profile for a total of 450 individuals, comprising 259 in the intervention group and 191 in the control group. Some studies have reported improvement in biochemical and clinical indicators, with limited adverse effects and good tolerance. It was not possible to determine, with the desired degree of evidence, the effect of curcumin supplementation in the treatment of cancer patients. It is important to consider the great heterogeneity and methodological weaknesses of the studies, and that it was not possible to perform a meta-analysis of the data available in the literature. |
id |
USP-31_e80c382350df125f6f0312d18313d259 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/200985 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Curcumin supplementation in the treatment of patients with cancer: a systematic reviewCurcumin. Cancer. Systematic review. Anti-inflammatory profile. Anti-oxidant profile.Feeding with high levels of phytochemicals, including curcumin, may be a therapeutic option for diseases such as cancer which is a public health problem. The aim of this study was to systematically review the results of clinical trials investigating the effect of oral curcumin supplementation on anti-inflammatory and antioxidant profiles, reduction of PSA levels and degree of dermatitis in radiotherapy treatment in cancer patients. The review was carried out based on the items of the PRISMA Statement. A bias risk assessment was performed according to Cochrane Collaboration criteria. Six studies met the eligibility criteria and were included in the systematic review. The results of this study are based on those obtained in the literature on the effect of curcumin on the anti-inflammatory profile, on reducing dermatitis, on PSA alteration and on anti-oxidant profile for a total of 450 individuals, comprising 259 in the intervention group and 191 in the control group. Some studies have reported improvement in biochemical and clinical indicators, with limited adverse effects and good tolerance. It was not possible to determine, with the desired degree of evidence, the effect of curcumin supplementation in the treatment of cancer patients. It is important to consider the great heterogeneity and methodological weaknesses of the studies, and that it was not possible to perform a meta-analysis of the data available in the literature.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2022-11-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/200985Brazilian Journal of Pharmaceutical Sciences; Vol. 57 (2021)Brazilian Journal of Pharmaceutical Sciences; v. 57 (2021)Brazilian Journal of Pharmaceutical Sciences; Vol. 57 (2021)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/200985/185166https://www.revistas.usp.br/bjps/article/view/200985/185167Copyright (c) 2022 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAndrade da Anunciação, Taise Spindola Garcez, LaísMiranda Pereira, EmileAlves de Oliveira Queiroz, ValterlindaRibas de Farias Costa, PriscilaPereira Magalhães de Oliveira, Lucivalda2022-11-08T19:43:44Zoai:revistas.usp.br:article/200985Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2022-11-08T19:43:44Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Curcumin supplementation in the treatment of patients with cancer: a systematic review |
title |
Curcumin supplementation in the treatment of patients with cancer: a systematic review |
spellingShingle |
Curcumin supplementation in the treatment of patients with cancer: a systematic review Andrade da Anunciação, Taise Curcumin. Cancer. Systematic review. Anti-inflammatory profile. Anti-oxidant profile. |
title_short |
Curcumin supplementation in the treatment of patients with cancer: a systematic review |
title_full |
Curcumin supplementation in the treatment of patients with cancer: a systematic review |
title_fullStr |
Curcumin supplementation in the treatment of patients with cancer: a systematic review |
title_full_unstemmed |
Curcumin supplementation in the treatment of patients with cancer: a systematic review |
title_sort |
Curcumin supplementation in the treatment of patients with cancer: a systematic review |
author |
Andrade da Anunciação, Taise |
author_facet |
Andrade da Anunciação, Taise Spindola Garcez, Laís Miranda Pereira, Emile Alves de Oliveira Queiroz, Valterlinda Ribas de Farias Costa, Priscila Pereira Magalhães de Oliveira, Lucivalda |
author_role |
author |
author2 |
Spindola Garcez, Laís Miranda Pereira, Emile Alves de Oliveira Queiroz, Valterlinda Ribas de Farias Costa, Priscila Pereira Magalhães de Oliveira, Lucivalda |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Andrade da Anunciação, Taise Spindola Garcez, Laís Miranda Pereira, Emile Alves de Oliveira Queiroz, Valterlinda Ribas de Farias Costa, Priscila Pereira Magalhães de Oliveira, Lucivalda |
dc.subject.por.fl_str_mv |
Curcumin. Cancer. Systematic review. Anti-inflammatory profile. Anti-oxidant profile. |
topic |
Curcumin. Cancer. Systematic review. Anti-inflammatory profile. Anti-oxidant profile. |
description |
Feeding with high levels of phytochemicals, including curcumin, may be a therapeutic option for diseases such as cancer which is a public health problem. The aim of this study was to systematically review the results of clinical trials investigating the effect of oral curcumin supplementation on anti-inflammatory and antioxidant profiles, reduction of PSA levels and degree of dermatitis in radiotherapy treatment in cancer patients. The review was carried out based on the items of the PRISMA Statement. A bias risk assessment was performed according to Cochrane Collaboration criteria. Six studies met the eligibility criteria and were included in the systematic review. The results of this study are based on those obtained in the literature on the effect of curcumin on the anti-inflammatory profile, on reducing dermatitis, on PSA alteration and on anti-oxidant profile for a total of 450 individuals, comprising 259 in the intervention group and 191 in the control group. Some studies have reported improvement in biochemical and clinical indicators, with limited adverse effects and good tolerance. It was not possible to determine, with the desired degree of evidence, the effect of curcumin supplementation in the treatment of cancer patients. It is important to consider the great heterogeneity and methodological weaknesses of the studies, and that it was not possible to perform a meta-analysis of the data available in the literature. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-11-08 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/200985 |
url |
https://www.revistas.usp.br/bjps/article/view/200985 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/200985/185166 https://www.revistas.usp.br/bjps/article/view/200985/185167 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 57 (2021) Brazilian Journal of Pharmaceutical Sciences; v. 57 (2021) Brazilian Journal of Pharmaceutical Sciences; Vol. 57 (2021) 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222915594027008 |